重度至极重度听力损失的成本与人工耳蜗植入的成本节约
研究利用美国全国健康访谈调查、全国健康与营养检查调查及联邦医疗保险费率数据,采用连续时间状态转移模型模拟患者一生,估算重度至极重度听力损失(SPHL)的终身成本及人工耳蜗植入的成本节约。结果显示,出生即患SPHL者终身成本为489,274美元,18个月前植入耳蜗者成本为390,931美元,未植入者为608,167美元;60岁发病者终身成本为154,536美元;结论认为SPHL是昂贵疾病,主要成本驱动为生产力损失,早期植入可大幅降低终身成本。
要点
- 出生即患SPHL者终身成本为489,274美元[377,518;616,519]。
- 18个月前植入耳蜗者终身成本为390,931美元[311,976;471,475],未植入者为608,167美元[442,544;791,719]。
核心结论
- SPHL是昂贵疾病,主要成本驱动为生产力损失;人工耳蜗植入医疗成本较高,但收入增加可抵消该成本;早期植入大幅降低终身成本。
- 作者认为听保健与技术的可及性至关重要,政府和保险政策应修改以实现听力技术的平等可及与覆盖,最终降低终身和社会成本。
研究设计与样本
- 研究数据来自美国全国健康访谈调查、全国健康与营养检查调查及联邦医疗保险费率。
- 采用连续时间状态转移模型结合个体患者模拟,估算SPHL终身成本。
- 模型包括四个状态:正常听力、重度至极重度听力损失、人工耳蜗植入和死亡。
主要发现
- 出生即患SPHL者终身成本为489,274美元[377,518;616,519]。
- 18个月前植入耳蜗者终身成本为390,931美元[311,976;471,475],未植入者为608,167美元[442,544;791,719]。
- 60岁发病者终身成本为154,536美元[7,093;302,936]。
临床怎么用
- 作者认为听保健与技术的可及性至关重要,政府和保险政策应修改以实现听力技术的平等可及与覆盖,最终降低终身和社会成本。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate costs of severe to profound hearing loss, including costs and cost-savings associated with cochlear implantation. METHODS: Data was obtained from the National Health Interview Survey, the National Health and Nutrition Examination Survey and national Medicare rates. We used continuous time state transition models with individual patient simulations to estimate the costs of severe to profound hearing loss (SPHL) across the lifespan. The model included four states, normal hearing, severe to profound hearing loss, cochlear implantation, and death. RESULTS: The estimated lifetime cost of an individual born with SPHL is $489,274 [377,518; 616,519]. Costs are lower for those who received a cochlear implant before 18 months of age $390,931 [311,976; 471,475], compared to those who are not implanted $608,167 [442,544; 791,719]. For individuals with a later onset of hearing loss (60 years old) lifetime costs were $154,536 [7,093; 302,936]. The annual societal costs for the US population were estimated to be $37 [8; 187] billion. CONCLUSIONS: SPHL is a costly condition, with the primary driver being lost productivity. Medical costs were higher for cochlear implantation, however, the higher income earnings offset the higher medical costs. Overall, early implantation substantially reduced lifetime costs. Access to hearing health care and technology is critical given the documented benefits for language, education, and quality of life. Government and insurance policies should be modified to allow for equal access and coverage for hearing technology, which will ultimately reduce lifetime and societal costs. LEVELS OF EVIDENCE: N/A The current study used existing nationally representative datasets. Thus, these levels of evidence do not apply. Laryngoscope, 134:4358-4365, 2024.
引用
- Cejas I, Barker DH, Petruzzello E, et al. Costs of Severe to Profound Hearing Loss & Cost Savings of Cochlear Implants. Laryngoscope. 2024. PMID: 38742597. doi:10.1002/lary.31497
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。